- Country: USA
- Summary: Purchase of (1R, 2R)-trans-N-Boc-1, 2 Cyclopentanediamine
- UST Ref No: 125129200
- Deadline: 03 Sep 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 75N94025Q00201
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation, and a separate written solicitation will not be issued. This solicitation number is 75N94025Q00201 and is issued as a Request for Quotation (RFQ). The solicitation/contract will include all applicable provisions and clauses in effect through Federal Acquisition Circular 2025-05. The North American Industry Classification (NAICS) Code is 325199 and the business size standard is 1250e. However, this solicitation is not set aside for small business. This acquisition is being conducted using Simplified Acquisition Procedures in accordance with FAR Part 13. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) intends to contract on a sole source basis with Cyclope Bio SL for the following products/requirements:
DA-03 100g (1R,2R)-trans-N-Boc-1,2 Cyclopentanediamine - Qty (100g) DA-13 100g (3R,4R)-trans-N-Boc-Tetrahydro-3,4-furandiamine - Qty (100g) DA-17 100g (3S,4S)-trans-N-Boc-Tetrahydro-3,4-furandiamine - Qty (100g) Research to develop route to RR and SS pyrrolidine analogs of DA-13 and DA-17, and delivery (if successful) of 1-5g of each enantiomerThe objective of the research is to advance the testing of thyclotides as probes to signal the presence of infection or disease. To properly make thyclotide oligomers, the lab must have the correct building blocks that will be made from these procured materials. Results from each set of tests done are added to the file that will eventually be submitted for FDA approval as a new diagnostic test. This is a continuity of services that Cyclope Bio has been providing for the lab for this ongoing project. Thus, changing vendors could lead to change in variables which would compromise the integrity of the ongoing project. Cyclope Bio will continu... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPurchase of (1R, 2R)-trans-N-Boc-1, 2 Cyclopentanediamine - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Purchase of (1R, 2R)-trans-N-Boc-1, 2 Cyclopentanediamine. This tender is published on USARFP under UST Ref No: 125129200 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-09-03.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
